<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5349668</article-id><article-id pub-id-type="pmid">28291838</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0173337</article-id><article-id pub-id-type="publisher-id">PONE-D-16-39546</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Disorders</subject><subj-group><subject>Diabetes Mellitus</subject><subj-group><subject>Type 2 Diabetes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Metabolic Disorders</subject><subj-group><subject>Diabetes Mellitus</subject><subj-group><subject>Type 2 Diabetes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Metabolic Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diabetes diagnosis and management</subject><subj-group><subject>HbA1c</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Hemoglobin</subject><subj-group><subject>HbA1c</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Electronics</subject><subj-group><subject>Accelerometers</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Fats</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Coronary Heart Disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Coronary Heart Disease</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Level and correlates of physical activity and sedentary behavior in patients with type 2 diabetes: A cross-sectional analysis of the Italian Diabetes and Exercise Study_2</article-title><alt-title alt-title-type="running-head">Physical activity and sedentariness in type 2 diabetes</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Balducci</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>D&#x02019;Errico</surname><given-names>Valeria</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Haxhi</surname><given-names>Jonida</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sacchetti</surname><given-names>Massimo</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Orlando</surname><given-names>Giorgio</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cardelli</surname><given-names>Patrizia</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Di Biase</surname><given-names>Nicolina</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bollanti</surname><given-names>Lucilla</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Conti</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zanuso</surname><given-names>Silvano</given-names></name><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nicolucci</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1574-0397</contrib-id><name><surname>Pugliese</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><collab>Italian Diabetes and Exercise Study 2 (IDES_2) Investigators</collab><xref ref-type="author-notes" rid="fn001"><sup>&#x000b6;</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Clinical and Molecular Medicine, &#x02018;&#x02018;La Sapienza&#x0201d; University, Rome, Italy</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Diabetes Unit, Sant&#x02019;Andrea Hospital, Rome, Italy</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Metabolic Fitness Association, Monterotondo, Rome, Italy</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Human Movement and Sport Sciences, &#x02018;&#x02018;Foro Italico&#x0201d; University, Rome, Italy</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Laboratory of Clinical Chemistry, Sant&#x02019;Andrea Hospital, Rome, Italy</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Diabetes Unit, Fatebenefratelli San Pietro Hospital, Rome, Italy</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Centre for Applied Biological &#x00026; Exercise Sciences, Faculty of Health &#x00026; Life Sciences, Coventry University, Coventry, United Kingdom</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Center for Outcomes Research and Clinical Epidemiology (CORE), Pescara, Italy</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Buchowski</surname><given-names>Maciej</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Vanderbilt University, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> SB GP.</p></list-item><list-item><p><bold>Data curation:</bold> SB AN GP.</p></list-item><list-item><p><bold>Formal analysis:</bold> AN GP.</p></list-item><list-item><p><bold>Funding acquisition:</bold> SB.</p></list-item><list-item><p><bold>Investigation:</bold> SB VDE JH MS GO PC NDB LB FC GP.</p></list-item><list-item><p><bold>Methodology:</bold> SB MS SZ AN GP.</p></list-item><list-item><p><bold>Project administration:</bold> SB GP.</p></list-item><list-item><p><bold>Resources:</bold> SB VDE JH NDB LB FC GP.</p></list-item><list-item><p><bold>Supervision:</bold> SB GP.</p></list-item><list-item><p><bold>Validation:</bold> SB VDE JH MS PC GP.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> GP.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> SB AN GP.</p></list-item></list>
</p></fn><fn fn-type="other" id="fn001"><p><sup>&#x000b6;</sup> A complete list of the IDES_2 Investigators can be found as supporting information (see S1 File).</p></fn><corresp id="cor001">* E-mail: <email>giuseppe.pugliese@uniroma1.it</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>3</issue><elocation-id>e0173337</elocation-id><history><date date-type="received"><day>4</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Balducci et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Balducci et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0173337.pdf"/><abstract><sec id="sec001"><title>Objective</title><p>Patients with type 2 diabetes usually show reduced physical activity (PA) and increased sedentary (SED)-time, though to a varying extent, especially for low-intensity PA (LPA), a major determinant of daily energy expenditure that is not accurately captured by questionnaires. This study assessed the level and correlates of PA and SED-time in patients from the Italian Diabetes and Exercise Study_2 (IDES_2).</p></sec><sec id="sec002"><title>Methods</title><p>Three-hundred physically inactive and sedentary patients with type 2 diabetes were enrolled in the IDES_2 to be randomized to an intervention group, receiving theoretical and practical exercise counseling, and a control group, receiving standard care. At baseline, LPA, moderate-to-vigorous-intensity PA (MVPA), and SED-time were measured by accelerometer. Physical fitness and cardiovascular risk factors and scores were also assessed.</p></sec><sec id="sec003"><title>Results</title><p>LPA was 3.93&#x000b1;1.35 hours&#x02219;day<sup>-1</sup>, MVPA was 12.4&#x000b1;4.6 min&#x02219;day<sup>-1</sup>, and SED-time was 11.6&#x000b1;1.2 hours&#x02219;day<sup>-1</sup>, with a large range of values (0.89&#x02013;7.11 hours&#x02219;day<sup>-1</sup>, 0.6&#x02013;21.0 min&#x02219;day<sup>-1</sup>, and 9.14&#x02013;15.28 hours&#x02219;day<sup>-1</sup>, respectively). At bivariate analysis, LPA and MVPA correlated with better cardiovascular risk profile and fitness parameters, whereas the opposite was observed for SED-time. Likewise, values of LPA, MVPA, and SED-time falling in the best tertile were associated with optimal or acceptable levels of cardiovascular risk factors and scores. At multivariate analysis, age, female gender, HbA<sub>1c</sub>, BMI or waist circumference, and high-sensitivity C reactive protein (for LPA and SED-time only) were negatively associated with LPA and MPA and positively associated with SED-time in an independent manner.</p></sec><sec id="sec004"><title>Conclusions</title><p>Physically inactive and sedentary patients with type 2 diabetes from the IDES_2 show a low level of PA, though values of LPA, MVPA, and SED-time vary largely. Furthermore, there is a strong correlation of these measures with glycemic control, adiposity and inflammation, thus suggesting that even small improvements in LPA, MVPA, and SED-time might be associated with significant improvement in cardiovascular risk profile.</p></sec><sec id="sec005"><title>Trial registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01600937">NCT01600937</ext-link></p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Metabolic Fitness Association</institution></funding-source><principal-award-recipient><name><surname>Balducci</surname><given-names>Stefano</given-names></name></principal-award-recipient></award-group><funding-statement>The work was supported by Metabolic Fitness Association, Monterotondo, Rome, Italy, <ext-link ext-link-type="uri" xlink:href="http://www.metabolicfitness.it/">http://www.metabolicfitness.it/</ext-link>. Grant Number: NA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="15"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>Physical inactivity, i.e. an insufficient amount of physical activity (PA) according to current guidelines, and sedentary behavior, i.e. a large amount of time spent in a sitting or reclining posture, have become the major determinants of the epidemic of obesity and type 2 diabetes. Recent data from the National Health and Nutrition Examination Survey (NHANES) indicate that the dramatic rise in the prevalence of obesity and abdominal adiposity among US adults from 1988 to 2010 was associated with an increased proportion of subjects reporting no leisure-time PA, but not with changes in average caloric intake [<xref rid="pone.0173337.ref001" ref-type="bibr">1</xref>]. Another report from the NHANES (1988&#x02013;2008) shows that less than 50% of US adults achieve the recommended PA level and ~30% of them engage in no PA at all, though projections to 2020 suggest some improvement [<xref rid="pone.0173337.ref002" ref-type="bibr">2</xref>]. The prevalence of physical inactivity is even higher in individuals with type 2 diabetes or in those at highest risk for developing this condition. In fact, in the Medical Expenditure Panel Survey, only 39% of adults with diabetes were physically active versus 58% of those without diabetes and the proportion of active adults without diabetes declined as the number of risk factors increased [<xref rid="pone.0173337.ref003" ref-type="bibr">3</xref>]. Physical inactivity is also a major predictor of all-cause mortality in subjects with type 2 diabetes [<xref rid="pone.0173337.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0173337.ref006" ref-type="bibr">6</xref>].</p><p>However, recent findings from individuals with type 2 diabetes indicate a significant association between sedentary (SED)-time and metabolic risk, independently of several confounders, including time spent in moderate-to-vigorous-intensity PA (MVPA). Indeed, MVPA was not associated with clustered metabolic risk after accounting for SED-time [<xref rid="pone.0173337.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0173337.ref008" ref-type="bibr">8</xref>]. These reports are consistent with previous studies showing a positive relationship between daily sitting time or television viewing with all-cause and cardiovascular mortality [<xref rid="pone.0173337.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0173337.ref010" ref-type="bibr">10</xref>] as well as cardiovascular risk factors [<xref rid="pone.0173337.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0173337.ref012" ref-type="bibr">12</xref>]. Taken together, the above observations support the concept that physically inactivity and sedentary behavior influence health outcomes through distinct pathways and highlight the need to target both conditions. In fact, the recommended amount of daily MVPA (30 min) [<xref rid="pone.0173337.ref013" ref-type="bibr">13</xref>] represents less than 5% of the time spent awake. Thus, additional efforts should be made to reduce sedentary behaviors during the rest of the day by promoting light-intensity PA (LPA), which is a major determinant of total daily energy expenditure and may be increased more easily than MVPA in patients with type 2 diabetes [<xref rid="pone.0173337.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0173337.ref015" ref-type="bibr">15</xref>]. A recent report from the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study showed that sitting-reduction strategies targeting increased standing, stepping, or both, may benefit cardio-metabolic health [<xref rid="pone.0173337.ref016" ref-type="bibr">16</xref>].</p><p>Although PA/exercise is now considered as a cornerstone of prevention and management of type 2 diabetes [<xref rid="pone.0173337.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0173337.ref018" ref-type="bibr">18</xref>], it is difficult to put into action PA/exercise recommendations for a number of barriers [<xref rid="pone.0173337.ref019" ref-type="bibr">19</xref>]. In particular, compliance is usually poor, since sustained changes in PA may require much time and effort. In fact, both randomized controlled trials (RCTs) and observational studies have shown that health benefits from PA/exercise may require large volumes [<xref rid="pone.0173337.ref020" ref-type="bibr">20</xref>&#x02013;<xref rid="pone.0173337.ref022" ref-type="bibr">22</xref>]. Nevertheless, in the long-term, even smaller volumes of daily PA may provide beneficial effects on glycemic control [<xref rid="pone.0173337.ref023" ref-type="bibr">23</xref>] and mortality [<xref rid="pone.0173337.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0173337.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0173337.ref025" ref-type="bibr">25</xref>]. Increasing total daily unstructured PA, mainly LPA, as suggested by current guidelines [<xref rid="pone.0173337.ref013" ref-type="bibr">13</xref>], may also reduce metabolic and cardiovascular risk in patients with type 2 diabetes by decreasing the amount of SED-time [<xref rid="pone.0173337.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0173337.ref015" ref-type="bibr">15</xref>].</p><p>While the time spent in MVPA is usually low in subjects with type 2 diabetes, the level of LPA and, conversely, the amount of SED-time may vary greatly, even in patients classified as physically inactive and sedentary according to current definitions. However, both LPA and SED-time are not accurately captured by questionnaires [<xref rid="pone.0173337.ref026" ref-type="bibr">26</xref>] and, hence, reliable data in patients with type 2 diabetes are lacking. In subjects without diagnosed diabetes from the AusDiab study, LPA was 5.8 hours&#x02219;day<sup>-1</sup>, MVPA was 36.0 min&#x02219;day<sup>-1</sup>, and SED-time was 8.4 hours&#x02219;day<sup>-1</sup>, on average, as measured objectively by accelerometer [<xref rid="pone.0173337.ref027" ref-type="bibr">27</xref>].</p><p>This study aimed at assessing the level and correlates of LPA, MVPA, and SED-time in physically inactive and sedentary patients with type 2 diabetes participating in the Italian Diabetes and Exercise Study_2 (IDES_2).</p></sec><sec id="sec007"><title>Subjects and methods</title><p>In this cross-sectional analysis, we used the data collected at the baseline visit for the IDES_2. This is an open-label, parallel RCT aimed at assessing the efficacy of a behavioral intervention strategy, as compared with standard medical care, in increasing total daily PA and reducing SED-time (primary endpoint) in patients with type 2 diabetes, as previously detailed [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>].</p><sec id="sec008"><title>Ethics</title><p>The study complies with the Declaration of Helsinki.</p><p>The research protocol, which follows the SPIRIT guideline, was approved by the Ethics Committee of Sant'Andrea Hospital (Prot. n. 212/2012) and written informed consent was provided by each participant.</p></sec><sec id="sec009"><title>Participants</title><p>The main entry criterion was known type 2 diabetes of at least 1-year duration. Additional requirements were age 40&#x02013;80 years, BMI 27&#x02013;40 kg/m<sup>2</sup>, physical inactivity (i.e. less than 150 min&#x02219;week<sup>-1</sup> of moderate to vigorous aerobic exercise spread out over at least 3 days during the week, with no more than 2 consecutive days between bouts of aerobic activity) [<xref rid="pone.0173337.ref029" ref-type="bibr">29</xref>], and sedentary lifestyle (i.e. more than 8 hours&#x02219;day<sup>-1</sup> spent in any waking behavior characterized by an energy expenditure &#x02264;1.5 metabolic equivalents [METs]) [<xref rid="pone.0173337.ref030" ref-type="bibr">30</xref>] from at least 6 months, ability to walk 1.6 Km without assistance, and eligibility after cardiologic evaluation.</p><p>The study was conducted in three tertiary referral outpatients Diabetes Clinics in Rome. From October 2012 to February 2014, three-hundred patients were recruited to be randomized 1:1 to an intervention (INT) group (n = 150), receiving theoretical [<xref rid="pone.0173337.ref021" ref-type="bibr">21</xref>] and practical [<xref rid="pone.0173337.ref031" ref-type="bibr">31</xref>] exercise counseling on top of standard care, and a control (CON) group (n = 150), receiving only standard care including general physician recommendations for daily PA [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>].</p></sec><sec id="sec010"><title>Measurements</title><p>At baseline, all patients were asked to wear an accelerometer for objectively assessing PA and SED-time. They also underwent assessment of physical fitness and measurement of anthropometrical, clinical and biochemical parameters. Data on socio-demographic characteristics of study subjects and presence of complications were also collected.</p><sec id="sec011"><title>Assessment of PA and SED-time</title><p>At screening, PA level was evaluated retrospectively using the Minnesota LTPA questionnaire [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>]. Each participant was then outfitted with a uni-axial piezoelectric accelerometer MyWellness Key (Technogym, Cesena, IT) [<xref rid="pone.0173337.ref032" ref-type="bibr">32</xref>], which offers the possibilities of storing 30 days of continuous movement detection and provides measures of the minutes spent at light, moderate and vigorous intensities and the total volume of PA, which are aligned with other laboratory validations [<xref rid="pone.0173337.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0173337.ref034" ref-type="bibr">34</xref>]. This device was recently shown to measure PA volume accurately and to acceptably discriminate between LPA and moderate intensity PA in individuals with type 2 diabetes [<xref rid="pone.0173337.ref035" ref-type="bibr">35</xref>]. Each participant wore the device for seven consecutive days. Upon waking, immediately after bathing or showering, participants were asked to attach the device at the waistband in midline of the right anterior hip and to wear it all day (except if swimming) up to bedtime. Patients were also asked to report on a daily diary the hours spent wearing the instrument, sleeping and snapping, and performing non-accelerometer recordable PAs such as swimming, cycling, skiing, etc.</p><p>The time the patient was awake and was not wearing the accelerometer was assumed to be spent in sedentary activities (e.g. taking a shower, getting dressed), unless the participant reported in the diary PAs which cannot be performed while wearing the accelerometer (e.g. swimming). SED-time was then calculated by adding this time to that recorded by the accelerometer with readings &#x0003c;100 counts&#x02219;min<sup>-1</sup>, a threshold which corresponds with sitting, reclining, or lying down, i.e. to &#x0003c;1.5 METS [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>].</p><p>Matthews&#x02019; cut-points were used to identify time spent in LPA (100&#x02013;1951 counts&#x02219;min<sup>-1</sup> corresponding to 1.5&#x02013;2.9 METs), whereas Freedson&#x02019;s cut-points were used to determine time spent in moderate intensity (1952&#x02013;5724 counts&#x02219;min<sup>-1</sup> corresponding to 3&#x02013;5.9 METs) and vigorous intensity (&#x0003e;5725 counts&#x02219;min<sup>-1</sup> corresponding to &#x0003e;6 METs) PA. Time spent in non-accelerometer recordable PAs, as reported on the daily diary, was added to that recorded by the accelerometer. Moderate intensity PA was combined with vigorous intensity PA into MVPAs, as participants spent little time in vigorous intensity PA [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>].</p></sec><sec id="sec012"><title>Assessment of physical fitness</title><p>Physical fitness was assessed by evaluating cardio-respiratory fitness, strength, and flexibility. The tests were preceded by two consecutive run-in sessions to become familiar with testing devices and protocols.</p><p>Cardio-respiratory fitness was assessed by a maximal treadmill exercise test using a Balke protocol and expressed as maximal oxygen uptake (VO<sub>2max</sub>), as previously detailed [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>]. Isometric muscle strength was measured by means of a strain gauge tensiometer (Digimax, Mechatronic GmbH, Germany) [<xref rid="pone.0173337.ref036" ref-type="bibr">36</xref>]. Lower limb muscle strength was assessed by maximal voluntary contractions (MVCs) performed at a costumed leg extension machine (Leg press, Easy Line, Technogym), with a 90&#x000b0; angle at the knee and the hip. Upper body muscle strength was assessed by MVCs performed at a shoulder press (Shoulder press/Lat pull, Easy Line, Technogym) along the sagittal plane, with a 90&#x000b0; and 45&#x000b0; angle at the elbow and between the upper arm and the trunk, respectively. For each exercise, three MVC were performed, with 3 min rest interval between contractions. For hip and trunk flexibility assessment, a standard bending test in the standing position was executed [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>]. The test was performed three times and the distance between the finger and the ground was measured at the third attempt.</p></sec><sec id="sec013"><title>Assessment of cardiovascular risk factors and scores</title><p>All patients underwent a structured interview in order to collect the following information: age, smoking status, known diabetes onset and duration, history of cardiovascular disease and microvascular complications, current treatments including glucose-, BP- and lipid-lowering drugs.</p><p>Body weight and height were measured using scale and stadiometer and BMI was then calculated as weight (kg)&#x02219;height<sup>-2</sup> (m<sup>-2</sup>), while waist circumference was taken at the umbilicus. Body composition was evaluated by assessing fat mass and fat-free mass by the use of a bio-impedance device (Tanita BF664, Vernon Hills, IL, USA). Then, BP was recorded with a sphygmomanometer after a five-minute rest with the patient seated with the arm at the heart level.</p><p>Biochemical tests were centralized at the Laboratory of Clinical Chemistry of Sant&#x02019;Andrea Hospital, an accredited and ISO9001 certified structure. The following parameters were assessed using standard analytical techniques [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>]: HbA<sub>1c</sub>, fasting plasma glucose (FPG), serum insulin, triglycerides, total, LDL and HDL cholesterol, high sensitivity-C-reactive protein (hs-CRP), serum creatinine, and albumin:creatinine ratio (ACR) on first-voided urine samples. Then, the Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) index was calculated from FPG and insulin levels; estimated glomerular filtration rate (eGFR) was computed from serum creatinine by the use of the Chronic Kidney Disease Epidemiology Collaboration equation; and global and fatal coronary heart disease (CHD) and stroke 10-year risk scores were calculated using the United Kingdom Prospective Diabetes Study (UKPDS) risk engine, as previously detailed [<xref rid="pone.0173337.ref028" ref-type="bibr">28</xref>].</p></sec></sec><sec id="sec014"><title>Statistical analysis</title><p>For the purpose of this analysis considering only baseline data, patients subsequently assigned to the INT and CON groups were pooled together. Data are expressed as mean &#x000b1; SD or number of cases (percentage). The &#x003c7;<sup>2</sup> test for categorical variables and the Student&#x02019;s t test or the corresponding nonparametric Mann-Whitney test for continuous variables were utilized to compare clinical characteristics between males and females. One-way ANOVA or the corresponding nonparametric Kruskal-Wallis test were used to evaluate changes of measured variables with tertiles of LPA, MPVA, and SED-time.</p><p>Bivariate analyses of correlations between LPA; MVPA, or SED-time and physical fitness parameters and cardiovascular risk factors and scores were performed using Spearman&#x02019;s rho. Partial correlation was also applied for adjusting each bivariate correlation for confounders. Then, multivariate regression analyses with stepwise backward selection of variables were applied to assess the independent correlates of LPA, MVPA, or SED-time. Covariates were age, gender, diabetes duration, HbA<sub>1c</sub>, HOMA-IR, BMI, fat mass, waist circumference, systolic BP, hs-CRP, eGFR, and ACR. Additional regression models were applied by including socio-demographic features or presence of long-term complications.</p><p>Statistical analyses were performed at the CORE using SAS software release 9.3 (Cary, NC, USA).</p></sec></sec><sec sec-type="results" id="sec015"><title>Results</title><sec id="sec016"><title>Clinical characteristics of study subjects</title><p>Patients from the IDES_2 cohort had a mean age of 61.6 years (SD 9.9), a mean diabetes duration of 10.5 years (SD 8.0), and a male-to-female ratio of 61/39. The clinical features of study subjects are reported in <xref rid="pone.0173337.t001" ref-type="table">Table 1</xref>.</p><table-wrap id="pone.0173337.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173337.t001</object-id><label>Table 1</label><caption><title>Clinical features, physical fitness parameters, and PA and SED-time values in the whole cohort and by gender.</title></caption><alternatives><graphic id="pone.0173337.t001g" xlink:href="pone.0173337.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Total</th><th align="center" rowspan="1" colspan="1">Males</th><th align="center" rowspan="1" colspan="1">Females</th><th align="left" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>n (%)</bold></td><td align="center" rowspan="1" colspan="1">300 (100)</td><td align="center" rowspan="1" colspan="1">184 (61.3)</td><td align="center" rowspan="1" colspan="1">116 (38.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age, years</bold></td><td align="center" rowspan="1" colspan="1">61.6&#x000b1;9.9</td><td align="center" rowspan="1" colspan="1">61.0&#x000b1;9.8</td><td align="center" rowspan="1" colspan="1">62.6&#x000b1;10.0</td><td align="char" char="." rowspan="1" colspan="1">0.163</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Smoking, n (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;<bold>Never</bold></td><td align="center" rowspan="1" colspan="1">122 (40.7)</td><td align="center" rowspan="1" colspan="1">41 (22.3)</td><td align="center" rowspan="1" colspan="1">81 (69.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;<bold>Former</bold></td><td align="center" rowspan="1" colspan="1">121 (40.3)</td><td align="center" rowspan="1" colspan="1">101 (54.9)</td><td align="center" rowspan="1" colspan="1">20 (17.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;<bold>Current</bold></td><td align="center" rowspan="1" colspan="1">57 (19.0)</td><td align="center" rowspan="1" colspan="1">42 (22.8)</td><td align="center" rowspan="1" colspan="1">15 (12.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Diabetes duration, years</bold></td><td align="center" rowspan="1" colspan="1">10.5&#x000b1;8.0</td><td align="center" rowspan="1" colspan="1">10.5&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">10.6&#x000b1;7.7</td><td align="char" char="." rowspan="1" colspan="1">0.711</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HbA</bold><sub><bold>1c</bold></sub><bold>, % (nmol&#x000b7;mol</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">7.38&#x000b1;1.49</td><td align="center" rowspan="1" colspan="1">7.33&#x000b1;1.41</td><td align="center" rowspan="1" colspan="1">7.45&#x000b1;1.61</td><td align="char" char="." rowspan="1" colspan="1">0.518</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">(57.1&#x000b1;16.3)</td><td align="center" rowspan="1" colspan="1">(56.6&#x000b1;15.4)</td><td align="center" rowspan="1" colspan="1">(57.9&#x000b1;17.6)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>FPG, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">7.56&#x000b1;2.73</td><td align="center" rowspan="1" colspan="1">7.47&#x000b1;2.48</td><td align="center" rowspan="1" colspan="1">7.70&#x000b1;3.09</td><td align="char" char="." rowspan="1" colspan="1">0.969</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Insulin, pmol&#x02219;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">89.3&#x000b1;86.2</td><td align="center" rowspan="1" colspan="1">86.7&#x000b1;91.3</td><td align="center" rowspan="1" colspan="1">93.4&#x000b1;77.6</td><td align="char" char="." rowspan="1" colspan="1">0.280</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HOMA-IR</bold></td><td align="center" rowspan="1" colspan="1">4.48&#x000b1;5.60</td><td align="center" rowspan="1" colspan="1">4.44&#x000b1;6.41</td><td align="center" rowspan="1" colspan="1">4.54&#x000b1;4.00</td><td align="char" char="." rowspan="1" colspan="1">0.292</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI, kg&#x000b7;m</bold><sup><bold>-2</bold></sup></td><td align="center" rowspan="1" colspan="1">30.0&#x000b1;5.1</td><td align="center" rowspan="1" colspan="1">29.1&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">31.4&#x000b1;5.6</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fat mass, %</bold></td><td align="center" rowspan="1" colspan="1">31.7&#x000b1;10.2</td><td align="center" rowspan="1" colspan="1">25.8&#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">40.9&#x000b1;6.0</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fat-free mass, kg</bold></td><td align="center" rowspan="1" colspan="1">56.5&#x000b1;11.3</td><td align="center" rowspan="1" colspan="1">63.1&#x000b1;8.2</td><td align="center" rowspan="1" colspan="1">45.9&#x000b1;6.6</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Waist circumference, cm</bold></td><td align="center" rowspan="1" colspan="1">103.6&#x000b1;12.8</td><td align="center" rowspan="1" colspan="1">103.1&#x000b1;12.5</td><td align="center" rowspan="1" colspan="1">104.5&#x000b1;13.2</td><td align="char" char="." rowspan="1" colspan="1">0.375</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Triglycerides, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">1.82&#x000b1;1.39</td><td align="center" rowspan="1" colspan="1">1.79&#x000b1;1.61</td><td align="center" rowspan="1" colspan="1">1.87&#x000b1;0.94</td><td align="char" char="." rowspan="1" colspan="1">0.049</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total cholesterol, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">4.67&#x000b1;1.01</td><td align="center" rowspan="1" colspan="1">4.55&#x000b1;0.98</td><td align="center" rowspan="1" colspan="1">4.86&#x000b1;1.02</td><td align="char" char="." rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HDL cholesterol, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">1.22&#x000b1;0.36</td><td align="center" rowspan="1" colspan="1">1.15&#x000b1;0.34</td><td align="center" rowspan="1" colspan="1">1.34&#x000b1;0.36</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LDL cholesterol, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">2.89&#x000b1;0.87</td><td align="center" rowspan="1" colspan="1">2.90&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">2.89&#x000b1;0.77</td><td align="char" char="." rowspan="1" colspan="1">0.931</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Systolic BP, mmHg</bold></td><td align="center" rowspan="1" colspan="1">140.1&#x000b1;20.4</td><td align="center" rowspan="1" colspan="1">138.9&#x000b1;18.6</td><td align="center" rowspan="1" colspan="1">142.0&#x000b1;23.0</td><td align="char" char="." rowspan="1" colspan="1">0.193</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Diastolic BP, mmHg</bold></td><td align="center" rowspan="1" colspan="1">82.9&#x000b1;11.7</td><td align="center" rowspan="1" colspan="1">83.0&#x000b1;11.3</td><td align="center" rowspan="1" colspan="1">82.7&#x000b1;12.3</td><td align="char" char="." rowspan="1" colspan="1">0.859</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>hs-CRP, mg&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">4.99&#x000b1;8.82</td><td align="center" rowspan="1" colspan="1">3.59&#x000b1;4.37</td><td align="center" rowspan="1" colspan="1">7.21&#x000b1;12.79</td><td align="char" char="." rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>eGFR, ml&#x000b7;min</bold><sup><bold>-1</bold></sup><bold>&#x000b7;1.73 m</bold><sup><bold>-2</bold></sup></td><td align="center" rowspan="1" colspan="1">87.1&#x000b1;18.4</td><td align="center" rowspan="1" colspan="1">87.7&#x000b1;18.1</td><td align="center" rowspan="1" colspan="1">86.2&#x000b1;19.0</td><td align="char" char="." rowspan="1" colspan="1">0.509</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ACR, mg&#x000b7;g</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">73.4&#x000b1;332.7</td><td align="center" rowspan="1" colspan="1">84.3&#x000b1;401.0</td><td align="center" rowspan="1" colspan="1">56.2&#x000b1;177.4</td><td align="char" char="." rowspan="1" colspan="1">0.132</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS CHD 10-year risk score</bold></td><td align="center" rowspan="1" colspan="1">20.6&#x000b1;13.8</td><td align="center" rowspan="1" colspan="1">24.7&#x000b1;14.8</td><td align="center" rowspan="1" colspan="1">14.3&#x000b1;9.0</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal CHD 10-year risk score</bold></td><td align="center" rowspan="1" colspan="1">15.1&#x000b1;12.8</td><td align="center" rowspan="1" colspan="1">17.8&#x000b1;14.1</td><td align="center" rowspan="1" colspan="1">10.7&#x000b1;8.8</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS stroke 10-year risk score</bold></td><td align="center" rowspan="1" colspan="1">13.4&#x000b1;12.7</td><td align="center" rowspan="1" colspan="1">14.7&#x000b1;14.0</td><td align="center" rowspan="1" colspan="1">11.2&#x000b1;9.8</td><td align="char" char="." rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal stroke 10-year risk score</bold></td><td align="center" rowspan="1" colspan="1">2.18&#x000b1;2.44</td><td align="center" rowspan="1" colspan="1">2.33&#x000b1;2.58</td><td align="center" rowspan="1" colspan="1">1.94&#x000b1;2.18</td><td align="char" char="." rowspan="1" colspan="1">0.211</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>VO</bold><sub><bold>2max</bold></sub><bold>, ml&#x02219;min</bold><sup><bold>-1</bold></sup><bold>&#x02219;kg</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">24.7&#x000b1;6.5</td><td align="center" rowspan="1" colspan="1">26.8&#x000b1;5.9</td><td align="center" rowspan="1" colspan="1">21.2&#x000b1;5.7</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Upper body strength, Nm</bold></td><td align="center" rowspan="1" colspan="1">254.8&#x000b1;92.5</td><td align="center" rowspan="1" colspan="1">299.4&#x000b1;80.3</td><td align="center" rowspan="1" colspan="1">184.1&#x000b1;61.6</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lower body strength, Nm</bold></td><td align="center" rowspan="1" colspan="1">161.1&#x000b1;60.4</td><td align="center" rowspan="1" colspan="1">188.8&#x000b1;53.9</td><td align="center" rowspan="1" colspan="1">117.3&#x000b1;41.1</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bending, cm</bold></td><td align="center" rowspan="1" colspan="1">16.7&#x000b1;11.7</td><td align="center" rowspan="1" colspan="1">18.1&#x000b1;11.0</td><td align="center" rowspan="1" colspan="1">14.5&#x000b1;12.4</td><td align="char" char="." rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LPA, hours&#x02219;day</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">3.93&#x000b1;1.35</td><td align="center" rowspan="1" colspan="1">4.20&#x000b1;1.36</td><td align="center" rowspan="1" colspan="1">3.50&#x000b1;1.24</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>MVPA, min&#x02219;day</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">12.4&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">13.8&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">10.1&#x000b1;4.4</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SED-time, hours&#x02219;day</bold><sup><bold>-1</bold></sup></td><td align="center" rowspan="1" colspan="1">11.6&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">11.4&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">11.9&#x000b1;1.2</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Values are mean&#x000b1;SD for continuous variables and n (%) for categorical variables.</p></fn><fn id="t001fn002"><p>PA = physical activity; SED-time = sedentary time; FPG = fasting plasma glucose; HOMA-IR = Homeostasis Model Assessment-Insulin Resistance; BP = blood pressure; hs-CRP = high sensitivity-C-reactive protein; eGFR = estimated glomerular filtration rate; ACR = albumin:creatinine ratio; UKPDS = United Kingdom Prospective Diabetes Study; CHD = coronary heart disease; VO<sub>2max</sub> = maximal oxygen uptake; LPA = light intensity PA; MVPA = moderate-to-vigorous intensity PA.</p></fn></table-wrap-foot></table-wrap><p>On average, they showed a reasonably good, though not optimal, control of glucose levels (mean HbA<sub>1c</sub> 7.38%) as well as of the other cardiovascular risk factors, with the possible exception of adiposity level and distribution, and a significant 10-year risk of CHD (&#x0003e;20%).</p><p>As previously reported [<xref rid="pone.0173337.ref037" ref-type="bibr">37</xref>], the cardiovascular risk profile was worse in females than in males, though the UKPDS CHD risk scores remained higher in men. Medication use is reported in <xref ref-type="supplementary-material" rid="pone.0173337.s002">S1 Table</xref> and was similar between males and females for most agents.</p></sec><sec id="sec017"><title>Level of PA and SED-time</title><p>As expected, physical fitness parameters indicated a low fitness and accelerometer measures showed a low amount of both LPA (mean value 3.93 hours&#x02219;day<sup>-1</sup>) and MVPA (mean value 12.4 min&#x02219;day<sup>-1</sup>) and a high level of SED-time (mean value 11.6 hours&#x02219;day<sup>-1</sup>) (<xref rid="pone.0173337.t001" ref-type="table">Table 1</xref>).</p><p>However, even if per protocol all patients were physically inactive and sedentary, the range of LPA (0.89&#x02013;7.11 hours&#x02219;day<sup>-1</sup>), MVPA (0.6&#x02013;21.0 min&#x02219;day<sup>-1</sup>), and SED-time (9.14&#x02013;15.28 hours&#x02219;day<sup>-1</sup>) values were quite wide (<xref ref-type="fig" rid="pone.0173337.g001">Fig 1</xref>).</p><fig id="pone.0173337.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173337.g001</object-id><label>Fig 1</label><caption><title>Distribution of LVPA, MVPA, and SED-time values in the study subjects.</title><p>Median (interquartile range) for each variable are reported on the right. LPA = light intensity physical activity; MVPA = moderate-to-vigorous intensity; SED-time = sedentary time.</p></caption><graphic xlink:href="pone.0173337.g001"/></fig></sec><sec id="sec018"><title>Correlates of PA and SED-time</title><p>Bivariate correlations (<xref rid="pone.0173337.t002" ref-type="table">Table 2</xref>) showed negative associations of both LPA and MVPA with age, diabetes duration, HbA<sub>1c</sub>, FPG, HOMA-IR, BMI, fat mass, waist circumference, hs-CRP, UKPDS risk scores, VO<sub>2max</sub>, strength, and SED-time. Only LPA correlated with ACR and bending, whereas only MVPA correlated with fat-free mass, triglycerides, systolic blood pressure, and eGFR. In contrast, SED-time was positively associated with age, diabetes duration, HbA<sub>1c</sub>, FPG, insulin, HOMA-IR, BMI, fat mass, waist circumference, triglycerides, systolic BP, hs-CRP, ACR, UKPDS risk scores, and physical fitness measures. When partial correlation analysis was applied to adjust for confounders, only age, HbA<sub>1c</sub>, BMI or fat mass, and hs-CRP remained significantly associated with LPA, MVPA and SED-time.</p><table-wrap id="pone.0173337.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173337.t002</object-id><label>Table 2</label><caption><title>Bivariate correlations of LVPA, MVPA, and SED-time with cardiovascular risk factors and scores and physical fitness parameters (Spearman&#x02019;s rho).</title></caption><alternatives><graphic id="pone.0173337.t002g" xlink:href="pone.0173337.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variable</th><th align="center" colspan="2" rowspan="1">LPA</th><th align="center" colspan="2" rowspan="1">MVPA</th><th align="center" colspan="2" rowspan="1">SED-time</th></tr><tr><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="center" rowspan="1" colspan="1">-0.198</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">-0.281</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.152</td><td align="char" char="." rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Diabetes duration</bold></td><td align="center" rowspan="1" colspan="1">-0.153</td><td align="char" char="." rowspan="1" colspan="1">0.008</td><td align="char" char="." rowspan="1" colspan="1">-0.178</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="char" char="." rowspan="1" colspan="1">0.167</td><td align="char" char="." rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HbA</bold><sub><bold>1c</bold></sub></td><td align="center" rowspan="1" colspan="1">-0.305</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.196</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">0.323</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>FPG</bold></td><td align="center" rowspan="1" colspan="1">-0.222</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.144</td><td align="char" char="." rowspan="1" colspan="1">0.012</td><td align="char" char="." rowspan="1" colspan="1">0.218</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Insulin</bold></td><td align="center" rowspan="1" colspan="1">-0.109</td><td align="char" char="." rowspan="1" colspan="1">0.059</td><td align="char" char="." rowspan="1" colspan="1">-0.100</td><td align="char" char="." rowspan="1" colspan="1">0.084</td><td align="char" char="." rowspan="1" colspan="1">0.139</td><td align="char" char="." rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HOMA-IR</bold></td><td align="center" rowspan="1" colspan="1">-0.180</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="char" char="." rowspan="1" colspan="1">-0.137</td><td align="char" char="." rowspan="1" colspan="1">0.018</td><td align="char" char="." rowspan="1" colspan="1">0.207</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI</bold></td><td align="center" rowspan="1" colspan="1">-0.248</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.218</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.225</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fat mass</bold></td><td align="center" rowspan="1" colspan="1">0.243</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.351</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.227</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Fat-free mass</bold></td><td align="center" rowspan="1" colspan="1">0.077</td><td align="char" char="." rowspan="1" colspan="1">0.183</td><td align="char" char="." rowspan="1" colspan="1">0.205</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.071</td><td align="char" char="." rowspan="1" colspan="1">0.224</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Waist circumference</bold></td><td align="center" rowspan="1" colspan="1">-0.230</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.214</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.200</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Triglycerides</bold></td><td align="center" rowspan="1" colspan="1">-0.111</td><td align="char" char="." rowspan="1" colspan="1">0.055</td><td align="char" char="." rowspan="1" colspan="1">-0.127</td><td align="char" char="." rowspan="1" colspan="1">0.027</td><td align="char" char="." rowspan="1" colspan="1">0.135</td><td align="char" char="." rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total cholesterol</bold></td><td align="center" rowspan="1" colspan="1">0.031</td><td align="char" char="." rowspan="1" colspan="1">0.596</td><td align="char" char="." rowspan="1" colspan="1">0.074</td><td align="char" char="." rowspan="1" colspan="1">0.199</td><td align="char" char="." rowspan="1" colspan="1">-0.026</td><td align="char" char="." rowspan="1" colspan="1">0.657</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HDL cholesterol</bold></td><td align="center" rowspan="1" colspan="1">0.048</td><td align="char" char="." rowspan="1" colspan="1">0.403</td><td align="char" char="." rowspan="1" colspan="1">0.021</td><td align="char" char="." rowspan="1" colspan="1">0.717</td><td align="char" char="." rowspan="1" colspan="1">-0.066</td><td align="char" char="." rowspan="1" colspan="1">0.253</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LDL cholesterol</bold></td><td align="center" rowspan="1" colspan="1">0.069</td><td align="char" char="." rowspan="1" colspan="1">0.233</td><td align="char" char="." rowspan="1" colspan="1">0.136</td><td align="char" char="." rowspan="1" colspan="1">0.018</td><td align="char" char="." rowspan="1" colspan="1">-0.074</td><td align="char" char="." rowspan="1" colspan="1">0.202</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Systolic BP</bold></td><td align="center" rowspan="1" colspan="1">-0.089</td><td align="char" char="." rowspan="1" colspan="1">0.124</td><td align="char" char="." rowspan="1" colspan="1">-0.177</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="char" char="." rowspan="1" colspan="1">0.116</td><td align="char" char="." rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Diastolic BP</bold></td><td align="center" rowspan="1" colspan="1">-0.003</td><td align="char" char="." rowspan="1" colspan="1">0.956</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">0.975</td><td align="char" char="." rowspan="1" colspan="1">0.028</td><td align="char" char="." rowspan="1" colspan="1">0.628</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>hs-CRP</bold></td><td align="center" rowspan="1" colspan="1">-0.226</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.256</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.202</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>eGFR</bold></td><td align="center" rowspan="1" colspan="1">0.093</td><td align="char" char="." rowspan="1" colspan="1">0.110</td><td align="char" char="." rowspan="1" colspan="1">0.136</td><td align="char" char="." rowspan="1" colspan="1">0.018</td><td align="char" char="." rowspan="1" colspan="1">-0.041</td><td align="char" char="." rowspan="1" colspan="1">0.479</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ACR</bold></td><td align="center" rowspan="1" colspan="1">-0.155</td><td align="char" char="." rowspan="1" colspan="1">0.007</td><td align="char" char="." rowspan="1" colspan="1">-0.035</td><td align="char" char="." rowspan="1" colspan="1">0.547</td><td align="char" char="." rowspan="1" colspan="1">0.136</td><td align="char" char="." rowspan="1" colspan="1">0.018</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS CHD risk score</bold></td><td align="center" rowspan="1" colspan="1">-0.162</td><td align="char" char="." rowspan="1" colspan="1">0.005</td><td align="char" char="." rowspan="1" colspan="1">-0.118</td><td align="char" char="." rowspan="1" colspan="1">0.042</td><td align="char" char="." rowspan="1" colspan="1">0.142</td><td align="char" char="." rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal CHD risk score</bold></td><td align="center" rowspan="1" colspan="1">-0.206</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.189</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">0.187</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS stroke risk score</bold></td><td align="center" rowspan="1" colspan="1">-0.182</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="char" char="." rowspan="1" colspan="1">-0.239</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.148</td><td align="char" char="." rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal stroke risk score</bold></td><td align="center" rowspan="1" colspan="1">-0187</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">-0.256</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.161</td><td align="char" char="." rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>VO</bold><sub><bold>2max</bold></sub></td><td align="center" rowspan="1" colspan="1">0.586</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.663</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.522</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Upper body strength</bold></td><td align="center" rowspan="1" colspan="1">0.281</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.397</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.235</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lower body strength</bold></td><td align="center" rowspan="1" colspan="1">0.341</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.412</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.299</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bending</bold></td><td align="center" rowspan="1" colspan="1">-0.143</td><td align="char" char="." rowspan="1" colspan="1">0.013</td><td align="char" char="." rowspan="1" colspan="1">-0.107</td><td align="char" char="." rowspan="1" colspan="1">0.064</td><td align="char" char="." rowspan="1" colspan="1">0.142</td><td align="char" char="." rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LPA</bold></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="char" char="." rowspan="1" colspan="1">0.591</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.855</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>MVPA</bold></td><td align="center" rowspan="1" colspan="1">0.591</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="char" char="." rowspan="1" colspan="1">-0.547</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SED-time</bold></td><td align="center" rowspan="1" colspan="1">-0.855</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.547</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>LPA = light intensity physical activity; MVPA = moderate-to-vigorous intensity; SED-time = sedentary time; FPG = fasting plasma glucose; HOMA-IR = Homeostasis Model Assessment-Insulin Resistance; BP = blood pressure; hs-CRP = high sensitivity-C-reactive protein; eGFR = estimated glomerular filtration rate; ACR = albumin:creatinine ratio; UKPDS = United Kingdom Prospective Diabetes Study; CHD = coronary heart disease; VO<sub>2max</sub> = maximal oxygen uptake.</p></fn></table-wrap-foot></table-wrap><p>Levels of HbA<sub>1c</sub>, FPG, HOMA-IR, BMI, fat mass, waist circumference, hs-CRP, ACR, UKPDS risk scores, and physical fitness parameters significantly improved with tertiles of LPA and worsened with tertiles of SED-time (except for ACR). A trend similar to that of LPA was observed with tertiles of MVPA, except for a significant decrease of systolic blood pressure, but not of FPG, ACR, total CHD risk score, and bending, and an increase in fat-free mass (<xref rid="pone.0173337.t003" ref-type="table">Table 3</xref>).</p><table-wrap id="pone.0173337.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173337.t003</object-id><label>Table 3</label><caption><title>Cardiovascular risk factors and scores and physical fitness parameters by tertiles of LVPA, MVPA, and SED-time.</title></caption><alternatives><graphic id="pone.0173337.t003g" xlink:href="pone.0173337.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="3" colspan="1">Variable</th><th align="center" colspan="4" rowspan="1">Tertiles of LPA (hours&#x02219;day<sup>-1</sup>)</th><th align="center" colspan="4" rowspan="1">Tertiles of MVPA (min&#x02219;day<sup>-1</sup>)</th><th align="center" colspan="4" rowspan="1">Tertiles of SED-time (hours&#x02219;day<sup>-1</sup>)</th></tr><tr><th align="left" rowspan="1" colspan="1">I (&#x0003c;3.25)</th><th align="left" rowspan="1" colspan="1">II (3.25&#x02013;4.57)</th><th align="left" rowspan="1" colspan="1">III (&#x0003e;4.57)</th><th align="left" rowspan="2" colspan="1"><italic>P</italic></th><th align="left" rowspan="1" colspan="1">I (&#x0003c;10.8)</th><th align="left" rowspan="1" colspan="1">II (10.8&#x02013;15.0)</th><th align="left" rowspan="1" colspan="1">III (&#x0003e;15.0)</th><th align="left" rowspan="2" colspan="1"><italic>P</italic></th><th align="left" rowspan="1" colspan="1">I (&#x0003c;10.9)</th><th align="left" rowspan="1" colspan="1">II (10.9&#x02013;12.1)</th><th align="left" rowspan="1" colspan="1">III (&#x0003e;12.1)</th><th align="left" rowspan="2" colspan="1"><italic>P</italic></th></tr><tr><th align="left" rowspan="1" colspan="1">2.42&#x000b1;0.61</th><th align="left" rowspan="1" colspan="1">3.90&#x000b1;0.35</th><th align="left" rowspan="1" colspan="1">5.46&#x000b1;0.61</th><th align="left" rowspan="1" colspan="1">7.0&#x000b1;2.5</th><th align="left" rowspan="1" colspan="1">12.5&#x000b1;1.0</th><th align="left" rowspan="1" colspan="1">17.3&#x000b1;1.7</th><th align="left" rowspan="1" colspan="1">10.3&#x000b1;0.4</th><th align="left" rowspan="1" colspan="1">11.5&#x000b1;0.4</th><th align="left" rowspan="1" colspan="1">12.9&#x000b1;0.7</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1"><bold>HbA</bold><sub><bold>1c</bold></sub><bold>, %</bold></td><td align="left" rowspan="1" colspan="1">7.93&#x000b1;1.62</td><td align="left" rowspan="1" colspan="1">7.38&#x000b1;1.40</td><td align="left" rowspan="1" colspan="1">6.82&#x000b1;1.21</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">7.63&#x000b1;1.61</td><td align="left" rowspan="1" colspan="1">7.50&#x000b1;1.45</td><td align="left" rowspan="1" colspan="1">7.02&#x000b1;1.34</td><td align="char" char="." rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">6.79&#x000b1;1.22</td><td align="left" rowspan="1" colspan="1">7.33&#x000b1;1.29</td><td align="left" rowspan="1" colspan="1">8.00&#x000b1;1.67</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>(nmol&#x000b7;mol</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="left" rowspan="1" colspan="1">(63.2&#x000b1;17.7)</td><td align="left" rowspan="1" colspan="1">(57.2&#x000b1;15.3)</td><td align="left" rowspan="1" colspan="1">(51.0&#x000b1;13.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(59.9&#x000b1;17.6)</td><td align="left" rowspan="1" colspan="1">(58.5&#x000b1;15.8)</td><td align="left" rowspan="1" colspan="1">(53.2&#x000b1;14.6)</td><td align="char" char="." rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(50.7&#x000b1;13.3)</td><td align="left" rowspan="1" colspan="1">(56.6&#x000b1;14.1)</td><td align="left" rowspan="1" colspan="1">(63.9&#x000b1;18.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>FPG, mmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="left" rowspan="1" colspan="1">8.19&#x000b1;2.92</td><td align="left" rowspan="1" colspan="1">7.69&#x000b1;2.82</td><td align="left" rowspan="1" colspan="1">6.80&#x000b1;2.24</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">8.01&#x000b1;3.10</td><td align="left" rowspan="1" colspan="1">7.80&#x000b1;2.80</td><td align="left" rowspan="1" colspan="1">6.91&#x000b1;2.13</td><td align="char" char="." rowspan="1" colspan="1">0.243</td><td align="left" rowspan="1" colspan="1">6.88&#x000b1;2.24</td><td align="left" rowspan="1" colspan="1">7.44&#x000b1;2.50</td><td align="left" rowspan="1" colspan="1">8.35&#x000b1;3.19</td><td align="char" char="." rowspan="1" colspan="1">0.002</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Insulin, pmol&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="left" rowspan="1" colspan="1">97.5&#x000b1;97.9</td><td align="left" rowspan="1" colspan="1">99.9&#x000b1;92.6</td><td align="left" rowspan="1" colspan="1">70.6&#x000b1;61.5</td><td align="char" char="." rowspan="1" colspan="1">0.012</td><td align="left" rowspan="1" colspan="1">95.3&#x000b1;81.6</td><td align="left" rowspan="1" colspan="1">91.6&#x000b1;88.0</td><td align="left" rowspan="1" colspan="1">81.6&#x000b1;89.0</td><td align="char" char="." rowspan="1" colspan="1">0.059</td><td align="left" rowspan="1" colspan="1">73.1&#x000b1;63.8</td><td align="left" rowspan="1" colspan="1">96.7&#x000b1;94.3</td><td align="left" rowspan="1" colspan="1">98.2&#x000b1;95.5</td><td align="char" char="." rowspan="1" colspan="1">0.060</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>HOMA-IR</bold></td><td align="left" rowspan="1" colspan="1">5.35&#x000b1;7.03</td><td align="left" rowspan="1" colspan="1">5.05&#x000b1;5.79</td><td align="left" rowspan="1" colspan="1">3.05&#x000b1;2.97</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">4.93&#x000b1;4.96</td><td align="left" rowspan="1" colspan="1">4.78&#x000b1;6.41</td><td align="left" rowspan="1" colspan="1">3.77&#x000b1;5.33</td><td align="char" char="." rowspan="1" colspan="1">0.426</td><td align="left" rowspan="1" colspan="1">3.20&#x000b1;3.10</td><td align="left" rowspan="1" colspan="1">4.75&#x000b1;5.78</td><td align="left" rowspan="1" colspan="1">5.49&#x000b1;7.02</td><td align="char" char="." rowspan="1" colspan="1">0.003</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>BMI, kg&#x000b7;m</bold><sup><bold>-2</bold></sup></td><td align="left" rowspan="1" colspan="1">31.5&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">29.8&#x000b1;4.9</td><td align="left" rowspan="1" colspan="1">28.7&#x000b1;4.4</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">31.6&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">29.6&#x000b1;5.1</td><td align="left" rowspan="1" colspan="1">28.9&#x000b1;4.3</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">28.3&#x000b1;4.1</td><td align="left" rowspan="1" colspan="1">30.8&#x000b1;5.3</td><td align="left" rowspan="1" colspan="1">31.0&#x000b1;5.4</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Fat mass, %</bold></td><td align="left" rowspan="1" colspan="1">34.2&#x000b1;10.5</td><td align="left" rowspan="1" colspan="1">32.0&#x000b1;10.0</td><td align="left" rowspan="1" colspan="1">28.8&#x000b1;9.4</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">36.3&#x000b1;10.3</td><td align="left" rowspan="1" colspan="1">31.1&#x000b1;9.6</td><td align="left" rowspan="1" colspan="1">27.8&#x000b1;8.8</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">27.5&#x000b1;8.7</td><td align="left" rowspan="1" colspan="1">34.4&#x000b1;10.2</td><td align="left" rowspan="1" colspan="1">33.1&#x000b1;10.3</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Fat-free mass, kg</bold></td><td align="left" rowspan="1" colspan="1">55.8&#x000b1;11.5</td><td align="left" rowspan="1" colspan="1">56.1&#x000b1;11.8</td><td align="left" rowspan="1" colspan="1">57.5&#x000b1;10.7</td><td align="char" char="." rowspan="1" colspan="1">0.518</td><td align="left" rowspan="1" colspan="1">54.0&#x000b1;11.7</td><td align="left" rowspan="1" colspan="1">56.1&#x000b1;12.0</td><td align="left" rowspan="1" colspan="1">59.1&#x000b1;9.8</td><td align="char" char="." rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1">58.0&#x000b1;10.7</td><td align="left" rowspan="1" colspan="1">55.1&#x000b1;11.0</td><td align="left" rowspan="1" colspan="1">56.2&#x000b1;12.2</td><td align="char" char="." rowspan="1" colspan="1">0.194</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Waist circumference, cm</bold></td><td align="left" rowspan="1" colspan="1">107.3&#x000b1;14.0</td><td align="left" rowspan="1" colspan="1">102.7&#x000b1;12.0</td><td align="left" rowspan="1" colspan="1">100.9&#x000b1;11.4</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">107.6&#x000b1;14.6</td><td align="left" rowspan="1" colspan="1">102.1&#x000b1;11.5</td><td align="left" rowspan="1" colspan="1">101.4&#x000b1;11.3</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">99.9&#x000b1;10.8</td><td align="left" rowspan="1" colspan="1">105.3&#x000b1;11.9</td><td align="left" rowspan="1" colspan="1">105.7&#x000b1;14.7</td><td align="char" char="." rowspan="1" colspan="1">0.002</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Systolic BP, mmHg</bold></td><td align="left" rowspan="1" colspan="1">143.5&#x000b1;22.4</td><td align="left" rowspan="1" colspan="1">137.4&#x000b1;16.6</td><td align="left" rowspan="1" colspan="1">139.4&#x000b1;21.5</td><td align="char" char="." rowspan="1" colspan="1">0.095</td><td align="left" rowspan="1" colspan="1">144.1&#x000b1;21.8</td><td align="left" rowspan="1" colspan="1">140.1&#x000b1;20.2</td><td align="left" rowspan="1" colspan="1">136.3&#x000b1;18.7</td><td align="char" char="." rowspan="1" colspan="1">0.025</td><td align="left" rowspan="1" colspan="1">137.7&#x000b1;19.3</td><td align="left" rowspan="1" colspan="1">137.7&#x000b1;17.6</td><td align="left" rowspan="1" colspan="1">144.8&#x000b1;23.3</td><td align="char" char="." rowspan="1" colspan="1">0.016</td></tr><tr><td align="justify" rowspan="1" colspan="1"><bold>Diastolic BP, mmHg</bold></td><td align="left" rowspan="1" colspan="1">83.6&#x000b1;14.0</td><td align="left" rowspan="1" colspan="1">82.1&#x000b1;10.0</td><td align="left" rowspan="1" colspan="1">82.9&#x000b1;10.7</td><td align="char" char="." rowspan="1" colspan="1">0.678</td><td align="left" rowspan="1" colspan="1">83.5&#x000b1;13.8</td><td align="left" rowspan="1" colspan="1">82.5&#x000b1;11.7</td><td align="left" rowspan="1" colspan="1">82.6&#x000b1;9.4</td><td align="char" char="." rowspan="1" colspan="1">0.797</td><td align="left" rowspan="1" colspan="1">82.3&#x000b1;9.8</td><td align="left" rowspan="1" colspan="1">82.4&#x000b1;10.1</td><td align="left" rowspan="1" colspan="1">84.0&#x000b1;14.5</td><td align="char" char="." rowspan="1" colspan="1">0.512</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>hs-CRP, mg&#x000b7;l</bold><sup><bold>-1</bold></sup></td><td align="left" rowspan="1" colspan="1">6.52&#x000b1;9.32</td><td align="left" rowspan="1" colspan="1">5.72&#x000b1;11.39</td><td align="left" rowspan="1" colspan="1">2.72&#x000b1;3.15</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">6.62&#x000b1;10.96</td><td align="left" rowspan="1" colspan="1">5.06&#x000b1;6.83</td><td align="left" rowspan="1" colspan="1">3.38&#x000b1;7.96</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">2.82&#x000b1;3.51</td><td align="left" rowspan="1" colspan="1">5.22&#x000b1;9.61</td><td align="left" rowspan="1" colspan="1">6.92&#x000b1;11.02</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>eGFR, ml&#x000b7;min</bold><sup><bold>-1</bold></sup><bold>&#x000b7;1.73 m</bold><sup><bold>-2</bold></sup></td><td align="left" rowspan="1" colspan="1">84.2&#x000b1;21.1</td><td align="left" rowspan="1" colspan="1">88.5&#x000b1;16.4</td><td align="left" rowspan="1" colspan="1">88.7&#x000b1;17.2</td><td align="char" char="." rowspan="1" colspan="1">0.153</td><td align="left" rowspan="1" colspan="1">84.2&#x000b1;19.9</td><td align="left" rowspan="1" colspan="1">87.0&#x000b1;18.3</td><td align="left" rowspan="1" colspan="1">89.9&#x000b1;16.8</td><td align="char" char="." rowspan="1" colspan="1">0.089</td><td align="left" rowspan="1" colspan="1">88.5&#x000b1;17.6</td><td align="left" rowspan="1" colspan="1">87.8&#x000b1;17.3</td><td align="left" rowspan="1" colspan="1">85.0&#x000b1;20.2</td><td align="char" char="." rowspan="1" colspan="1">0.364</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>ACR, mg&#x000b7;g</bold><sup><bold>-1</bold></sup></td><td align="left" rowspan="1" colspan="1">116.1&#x000b1;521.6</td><td align="left" rowspan="1" colspan="1">65.1&#x000b1;158.6</td><td align="left" rowspan="1" colspan="1">39.1&#x000b1;184.7</td><td align="char" char="." rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">109.2&#x000b1;524.2</td><td align="left" rowspan="1" colspan="1">54.5&#x000b1;151.1</td><td align="left" rowspan="1" colspan="1">57.6&#x000b1;198.2</td><td align="char" char="." rowspan="1" colspan="1">0.841</td><td align="left" rowspan="1" colspan="1">48.5&#x000b1;192.0</td><td align="left" rowspan="1" colspan="1">50.7&#x000b1;136.3</td><td align="left" rowspan="1" colspan="1">121.1&#x000b1;524.9</td><td align="char" char="." rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS CHD 10-year risk score</bold></td><td align="left" rowspan="1" colspan="1">24.4&#x000b1;14.4</td><td align="left" rowspan="1" colspan="1">19.1&#x000b1;14.0</td><td align="left" rowspan="1" colspan="1">18.4&#x000b1;12.3</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">21.4&#x000b1;12.5</td><td align="left" rowspan="1" colspan="1">21.9&#x000b1;16.5</td><td align="left" rowspan="1" colspan="1">18.7&#x000b1;11.9</td><td align="char" char="." rowspan="1" colspan="1">0.381</td><td align="left" rowspan="1" colspan="1">19.3&#x000b1;12.8</td><td align="left" rowspan="1" colspan="1">18.1&#x000b1;12.7</td><td align="left" rowspan="1" colspan="1">24.5&#x000b1;15.1</td><td align="char" char="." rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal CHD 10-year risk score</bold></td><td align="left" rowspan="1" colspan="1">18.9&#x000b1;13.4</td><td align="left" rowspan="1" colspan="1">13.7&#x000b1;12.8</td><td align="left" rowspan="1" colspan="1">12.5&#x000b1;11.3</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">16.4&#x000b1;11.5</td><td align="left" rowspan="1" colspan="1">16.3&#x000b1;15.3</td><td align="left" rowspan="1" colspan="1">12.6&#x000b1;11.0</td><td align="char" char="." rowspan="1" colspan="1">0.037</td><td align="left" rowspan="1" colspan="1">13.2&#x000b1;11.8</td><td align="left" rowspan="1" colspan="1">13.1&#x000b1;11.6</td><td align="left" rowspan="1" colspan="1">18.9&#x000b1;14.1</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS stroke 10-year risk score</bold></td><td align="left" rowspan="1" colspan="1">16.5&#x000b1;13.8</td><td align="left" rowspan="1" colspan="1">12.8&#x000b1;13.1</td><td align="left" rowspan="1" colspan="1">10.7&#x000b1;10.2</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">15.7&#x000b1;12.8</td><td align="left" rowspan="1" colspan="1">13.8&#x000b1;14.1</td><td align="left" rowspan="1" colspan="1">10.7&#x000b1;10.6</td><td align="char" char="." rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1">11.6&#x000b1;11.1</td><td align="left" rowspan="1" colspan="1">12.4&#x000b1;12.2</td><td align="left" rowspan="1" colspan="1">16.1&#x000b1;14.2</td><td align="char" char="." rowspan="1" colspan="1">0.030</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>UKPDS fatal stroke 10-year risk score</bold></td><td align="left" rowspan="1" colspan="1">2.80&#x000b1;2.83</td><td align="left" rowspan="1" colspan="1">1.97&#x000b1;2.09</td><td align="left" rowspan="1" colspan="1">1.77&#x000b1;2.23</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">2.67&#x000b1;2.60</td><td align="left" rowspan="1" colspan="1">2.20&#x000b1;2.42</td><td align="left" rowspan="1" colspan="1">1.70&#x000b1;2.21</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">1.84&#x000b1;2.29</td><td align="left" rowspan="1" colspan="1">1.91&#x000b1;1.91</td><td align="left" rowspan="1" colspan="1">2.78&#x000b1;2.91</td><td align="char" char="." rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>VO</bold><sub><bold>2max</bold></sub><bold>, ml&#x02219;min</bold><sup><bold>-1</bold></sup><bold>&#x02219;kg</bold><sup><bold>-1</bold></sup></td><td align="left" rowspan="1" colspan="1">20.4&#x000b1;6.0</td><td align="left" rowspan="1" colspan="1">24.5&#x000b1;5.1</td><td align="left" rowspan="1" colspan="1">29.1&#x000b1;5.0</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">19.8&#x000b1;5.4</td><td align="left" rowspan="1" colspan="1">24.5&#x000b1;4.6</td><td align="left" rowspan="1" colspan="1">29.3&#x000b1;5.5</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">28.7&#x000b1;5.1</td><td align="left" rowspan="1" colspan="1">24.2&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">21.0&#x000b1;6.2</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Upper body strength, Nm</bold></td><td align="left" rowspan="1" colspan="1">225.1&#x000b1;86.9</td><td align="left" rowspan="1" colspan="1">254.9&#x000b1;90.6</td><td align="left" rowspan="1" colspan="1">284.4&#x000b1;91.3</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">215.6&#x000b1;86.1</td><td align="left" rowspan="1" colspan="1">257.0&#x000b1;93.2</td><td align="left" rowspan="1" colspan="1">289.7&#x000b1;83.7</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">284.3&#x000b1;85.6</td><td align="left" rowspan="1" colspan="1">246.7&#x000b1;90.6</td><td align="left" rowspan="1" colspan="1">233.5&#x000b1;94.5</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Lower body strength, Nm</bold></td><td align="left" rowspan="1" colspan="1">136.5&#x000b1;49.2</td><td align="left" rowspan="1" colspan="1">160.7&#x000b1;61.4</td><td align="left" rowspan="1" colspan="1">186.2&#x000b1;59.7</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">132.9&#x000b1;51.3</td><td align="left" rowspan="1" colspan="1">163.4&#x000b1;56.2</td><td align="left" rowspan="1" colspan="1">185.5&#x000b1;61.3</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="left" rowspan="1" colspan="1">184.0&#x000b1;59.4</td><td align="left" rowspan="1" colspan="1">161.8&#x000b1;61.4</td><td align="left" rowspan="1" colspan="1">137.6&#x000b1;51.2</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bending, cm</bold></td><td align="left" rowspan="1" colspan="1">19.7&#x000b1;12.0</td><td align="left" rowspan="1" colspan="1">14.5&#x000b1;11.6</td><td align="left" rowspan="1" colspan="1">15.9&#x000b1;11.0</td><td align="char" char="." rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">17.4&#x000b1;12.7</td><td align="left" rowspan="1" colspan="1">17.1&#x000b1;12.1</td><td align="left" rowspan="1" colspan="1">15.7&#x000b1;10.4</td><td align="char" char="." rowspan="1" colspan="1">0.559</td><td align="left" rowspan="1" colspan="1">15.8&#x000b1;11.0</td><td align="left" rowspan="1" colspan="1">14.2&#x000b1;11.4</td><td align="left" rowspan="1" colspan="1">20.2&#x000b1;11.9</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Values are mean&#x000b1;SD. LPA = light intensity physical activity; MVPA = moderate-to-vigorous intensity; SED-time = sedentary time; FPG = fasting plasma glucose; HOMA-IR = Homeostasis Model Assessment-Insulin Resistance; BP = blood pressure; hs-CRP = high sensitivity-C-reactive protein; eGFR = estimated glomerular filtration rate; ACR = albumin:creatinine ratio; UKPDS = United Kingdom Prospective Diabetes Study; CHD = coronary heart disease; VO<sub>2max</sub> = maximal oxygen uptake.</p></fn></table-wrap-foot></table-wrap><p>At multivariate analysis, age, female gender, HbA<sub>1c</sub>, BMI (for LPA) or waist circumference (for MVPA and SED-time), and hs-CRP (for LPA and SED-time only) were negatively associated with LPA and MPA and positively associated with SED-time in an independent manner (<xref rid="pone.0173337.t004" ref-type="table">Table 4</xref>). The total fraction of variance in LPA, MPA, and SED-time accounted for by variables included in multiple regression models were 22.7%, 28.4%, and 21.0%, respectively. Results did not change when socio-demographic characteristics or presence of complications were included in the models. These variables were not or minimally associated with LPA, MPA, and SED-time when analyzed in regression models including only age and gender (not shown).</p><table-wrap id="pone.0173337.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173337.t004</object-id><label>Table 4</label><caption><title>Independent correlates of PA and SED-time (multiple regression analysis with stepwise backward selection of variables).</title></caption><alternatives><graphic id="pone.0173337.t004g" xlink:href="pone.0173337.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variable</th><th align="center" colspan="2" rowspan="1">LPA</th><th align="center" colspan="2" rowspan="1">MVPA</th><th align="center" colspan="2" rowspan="1">SED-time</th></tr><tr><th align="center" rowspan="1" colspan="1">Beta</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">Beta</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">Beta</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="char" char="." rowspan="1" colspan="1">-0.175</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">-0.262</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.144</td><td align="char" char="." rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Female gender</bold></td><td align="char" char="." rowspan="1" colspan="1">-0.323</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">-0.332</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">0.137</td><td align="char" char="." rowspan="1" colspan="1">0.011</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>HbA</bold><sub><bold>1c</bold></sub></td><td align="char" char="." rowspan="1" colspan="1">-0.246</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="char" char="." rowspan="1" colspan="1">-0.165</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="char" char="." rowspan="1" colspan="1">0.310</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI</bold></td><td align="char" char="." rowspan="1" colspan="1">-0.326</td><td align="char" char="." rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Waist circumference</bold></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="char" char="." rowspan="1" colspan="1">-0.155</td><td align="char" char="." rowspan="1" colspan="1">0.002</td><td align="char" char="." rowspan="1" colspan="1">0.122</td><td align="char" char="." rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>hs-CRP</bold></td><td align="char" char="." rowspan="1" colspan="1">-0.135</td><td align="char" char="." rowspan="1" colspan="1">0.013</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="char" char="." rowspan="1" colspan="1">0.177</td><td align="char" char="." rowspan="1" colspan="1">0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>PA = physical activity; SED-time = sedentary time; LPA = light intensity PA; MVPA = moderate-to-vigorous intensity PA; hs-CRP = high sensitivity-C-reactive protein.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>This work provides, for the first time, an objective picture of the level of PA and sedentary behavior in patients with type 2 diabetes willing to participate in a research-based PA trial and identifies the main correlates of LPA, MVPA, and SED-time in these individuals.</p><sec id="sec020"><title>Level of PA and SED-time</title><p>The main findings of this study are the low level of PA / high level of sedentary behavior in patients with type 2 diabetes and the large variability of accelerometer measures in individuals who are classified as physically inactive and sedentary according to current definitions. In fact, on average, study subjects showed accelerometer-derived measures of LPA, MVPA, and SED-time which were worse than those observed in nondiabetic individuals from the AusDiab [<xref rid="pone.0173337.ref027" ref-type="bibr">27</xref>]. Moreover, half of participants in the IDES_2 fell in a range LPA (2.96&#x02013;4.93 hours&#x02219;day<sup>-1</sup>), MVPA (9.0&#x02013;16.0 min&#x02219;day<sup>-1</sup>), and SED-time (10.6&#x02013;12.4 hours&#x02219;day<sup>-1</sup>) far from the thresholds indicated by current guidelines [<xref rid="pone.0173337.ref013" ref-type="bibr">13</xref>]. These observations indicate that there is a large room for action in order to increase PA level and to decrease SED-time to the recommended levels in patients with type 2 diabetes.</p><p>The very strong correlation between LPA and SED-time confirms the close inverse association between the two parameters and supports the recommendation to increase not only MVPA, but also LPA, in order to contrast the independent deleterious effect of sedentary behavior on health outcomes [<xref rid="pone.0173337.ref013" ref-type="bibr">13</xref>]. As suggested by others [<xref rid="pone.0173337.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0173337.ref015" ref-type="bibr">15</xref>], increasing LPA might represent the first step toward the adoption of a physically active lifestyle, as it would reduce SED-time and increase physical function, thus allowing patients to subsequently engage in MVPA.</p><p>Some subjects were found to engage in virtually no PA and to spend almost all the time in a sitting or reclining position, whereas some other individuals approached the recommended levels. This finding suggests that prescription of PA/exercise to patients with type 2 diabetes should be preceded by an accurate evaluation of behavior of each individual, with particular reference to the amount of daily unstructured PAs and time spent in sitting or reclining position, in order to provide patients with adequate and specific recommendations.</p></sec><sec id="sec021"><title>Correlates of PA and SED-time</title><p>The close associations of accelerometer measures with virtually all metabolic parameters and cardiovascular risk factors and scores support the importance of increasing LPA (and MVPA) and concurrently decreasing SED-time. In particular, this analysis highlights the link between PA behavior and glycemic control, adiposity and inflammation, with HbA<sub>1c</sub>, BMI or waist circumference, and hs-CRP correlating independently with LPA, MVPA, and SED-time, together with age and gender. These observations are consistent with the recognized role of physically inactivity and sedentary behavior in the ongoing epidemic of obesity and type 2 diabetes [<xref rid="pone.0173337.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0173337.ref002" ref-type="bibr">2</xref>]. They are also in agreement with current guidelines considering PA/exercise as a cornerstone in the prevention and management of type 2 diabetes [<xref rid="pone.0173337.ref013" ref-type="bibr">13</xref>] as well as with the anti-inflammatory effect of PA/exercise [<xref rid="pone.0173337.ref038" ref-type="bibr">38</xref>], which was shown to reduce markers of inflammation and insulin resistance, independent of weight loss [<xref rid="pone.0173337.ref039" ref-type="bibr">39</xref>].</p><p>More importantly, these data indicate that small improvements in LPA, MVPA, and SED-time might be associated with better glycemic control and cardiovascular risk profile, even if absolute values remain quite distant from recommended levels. In fact, values of LPA, MVPA, and SED-time falling in the best tertile (i.e. &#x0003e;4.57 hours&#x02219;day<sup>-1</sup>, &#x0003e;15.0 min&#x02219;day<sup>-1</sup>, and &#x0003c;10.86 hours&#x02219;day<sup>-1</sup>, respectively) were shown to be associated with optimal or acceptable levels of metabolic parameters and cardiovascular risk factors and scores, whereas the opposite was observed for values in the worst tertiles. These findings support the concept that even limited behavioral changes with small volumes of daily PA, mainly of low intensity, may provide beneficial effects in patients with type 2 diabetes [<xref rid="pone.0173337.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0173337.ref023" ref-type="bibr">23</xref>&#x02013;<xref rid="pone.0173337.ref025" ref-type="bibr">25</xref>], thus suggesting the need to encourage all patients to be more active, while setting more or less ambitious goals based on the individual attitude and compliance. However, due to the cross-sectional nature of this analysis, this hypothesis needs to be confirmed by intervention studies, such as the IDES_2. In fact, a poor cardiovascular risk profile might be the cause, rather than the effect, of physical inactivity and/or sedentary behavior, though the beneficial impact of increasing PA and reducing sedentary SED-time on glycemic control and modifiable cardiovascular risk factors is well-established.</p></sec><sec id="sec022"><title>Strengths and limitations</title><p>A major strength of our study is that this is the first report on objective measures of PA and SED-time in a large contemporary cohort of patients with type 2 diabetes, very well characterized for cardio-metabolic risk profile and physical fitness level.</p><p>One limitation is the cross-sectional design, which does not allow assessing cause-effect relationships. Finally, the IDES_2 cohort is not fully representative of patients with type 2 diabetes, as subjects having any condition limiting/contraindicating PA or achieving the recommended level of PA were excluded. However, this analysis was specifically aimed at assessing the PA and SED-time profile of physically inactive and sedentary patients with type 2 diabetes, who represent the vast majority of the individuals suffering from this condition and those who are candidate to receive (and may benefit from) a behavioral intervention for adopting a physically active lifestyle.</p></sec><sec id="sec023"><title>Conclusions</title><p>In conclusion, the objective assessment of PA behavior by accelerometer in physically inactive and sedentary patients with type 2 diabetes from the IDES_2 showed that level of PA is low in these individuals, though values of LPA, MVPA, and SED-time vary largely.</p><p>Furthermore, there is a strong correlation between these measures and cardio-metabolic risk profile, with an independent association with HbA<sub>1c</sub>, BMI or waist circumference, and hs-CRP, in addition to age and gender.</p></sec></sec><sec sec-type="supplementary-material" id="sec024"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0173337.s001"><label>S1 File</label><caption><title>IDES_2 Investigators.</title><p>Diabetes Clinics; Metabolic Fitness Centers; Central laboratory; Data management team; Steering Committee.</p><p>(DOCX)</p></caption><media xlink:href="pone.0173337.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0173337.s002"><label>S1 Table</label><caption><title>Medication use in the whole cohort and by gender.</title><p>(DOCX)</p></caption><media xlink:href="pone.0173337.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The Authors thank the IDES_2 Investigators for participating in this study.</p></ack><ref-list><title>References</title><ref id="pone.0173337.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Ladabaum</surname><given-names>U</given-names></name>, <name><surname>Mannalithara</surname><given-names>A</given-names></name>, <name><surname>Myer</surname><given-names>PA</given-names></name>, <name><surname>Singh</surname><given-names>G</given-names></name>. <article-title>Obesity, abdominal obesity, physical activity, and caloric intake in U.S. Adults: 1988&#x02013;2010</article-title>. <source>Am J Med</source>. <year>2014</year>; <volume>127</volume>:<fpage>717</fpage>&#x02013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2014.02.026</pub-id>
<?supplied-pmid 24631411?><pub-id pub-id-type="pmid">24631411</pub-id></mixed-citation></ref><ref id="pone.0173337.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Huffman</surname><given-names>MD</given-names></name>, <name><surname>Capewell</surname><given-names>S</given-names></name>, <name><surname>Ning</surname><given-names>H</given-names></name>, <name><surname>Shay</surname><given-names>CM</given-names></name>, <name><surname>Ford</surname><given-names>ES</given-names></name>, <name><surname>Lloyd-Jones</surname><given-names>DM</given-names></name>. <article-title>Cardiovascular health behavior and health factor changes (1988&#x02013;2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys</article-title>. <source>Circulation</source>. <year>2012</year>; <volume>125</volume>:<fpage>2595</fpage>&#x02013;<lpage>2602</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.070722</pub-id>
<?supplied-pmid 22547667?><pub-id pub-id-type="pmid">22547667</pub-id></mixed-citation></ref><ref id="pone.0173337.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Morrato</surname><given-names>EH</given-names></name>, <name><surname>Hill</surname><given-names>JO</given-names></name>, <name><surname>Wyatt</surname><given-names>HR</given-names></name>, <name><surname>Ghushchyan</surname><given-names>V</given-names></name>, <name><surname>Sullivan</surname><given-names>PW</given-names></name>. <article-title>Physical activity in U.S. adults with diabetes and at risk for developing diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>; <volume>30</volume>:<fpage>203</fpage>&#x02013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.2337/dc06-1128</pub-id>
<?supplied-pmid 17259482?><pub-id pub-id-type="pmid">17259482</pub-id></mixed-citation></ref><ref id="pone.0173337.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>M</given-names></name>, <name><surname>Gibbons</surname><given-names>LW</given-names></name>, <name><surname>Kampert</surname><given-names>JB</given-names></name>, <name><surname>Nichaman</surname><given-names>MZ</given-names></name>, <name><surname>Blair</surname><given-names>SN</given-names></name>. <article-title>Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with Type 2 diabetes</article-title>. <source>Ann Intern Med</source>. <year>2000</year>; <volume>132</volume>:<fpage>605</fpage>&#x02013;<lpage>611</lpage>. <?supplied-pmid 10766678?><pub-id pub-id-type="pmid">10766678</pub-id></mixed-citation></ref><ref id="pone.0173337.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Prakash</surname><given-names>M</given-names></name>, <name><surname>Froelicher</surname><given-names>V</given-names></name>, <name><surname>Do</surname><given-names>D</given-names></name>, <name><surname>Partington</surname><given-names>S</given-names></name>, <name><surname>Atwood</surname><given-names>JE</given-names></name>. <article-title>Exercise capacity and mortality among men referred for exercise testing</article-title>. <source>N Engl J Med</source>. <year>2002</year>; <volume>346</volume>:<fpage>793</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa011858</pub-id>
<?supplied-pmid 11893790?><pub-id pub-id-type="pmid">11893790</pub-id></mixed-citation></ref><ref id="pone.0173337.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Church</surname><given-names>TS</given-names></name>, <name><surname>Cheng</surname><given-names>YJ</given-names></name>, <name><surname>Earnest</surname><given-names>CP</given-names></name>, <name><surname>Barlow</surname><given-names>CE</given-names></name>, <name><surname>Gibbons</surname><given-names>LW</given-names></name>, <name><surname>Priest</surname><given-names>EL</given-names></name>, <etal>et al</etal>
<article-title>Exercise capacity and body composition as predictors of mortality among men with diabetes</article-title>. <source>Diabetes Care</source>. <year>2004</year>; <volume>27</volume>:<fpage>83</fpage>&#x02013;<lpage>88</lpage>. <?supplied-pmid 14693971?><pub-id pub-id-type="pmid">14693971</pub-id></mixed-citation></ref><ref id="pone.0173337.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>AR</given-names></name>, <name><surname>Sebire</surname><given-names>S</given-names></name>, <name><surname>Montgomery</surname><given-names>AA</given-names></name>, <name><surname>Peters</surname><given-names>TJ</given-names></name>, <name><surname>Sharp</surname><given-names>DJ</given-names></name>, <name><surname>Jackson</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes</article-title>. <source>Diabetologia</source>. <year>2012</year>; <volume>55</volume>:<fpage>589</fpage>&#x02013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-011-2408-x</pub-id>
<?supplied-pmid 22167127?><pub-id pub-id-type="pmid">22167127</pub-id></mixed-citation></ref><ref id="pone.0173337.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>AJ</given-names></name>, <name><surname>Brage</surname><given-names>S</given-names></name>, <name><surname>Ekelund</surname><given-names>U</given-names></name>, <name><surname>Wareham</surname><given-names>NJ</given-names></name>, <name><surname>Griffin</surname><given-names>SJ</given-names></name>, <name><surname>Simmons</surname><given-names>RK</given-names></name>. <article-title>Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes</article-title>. <source>Diabetologia</source>. <year>2014</year>; <volume>57</volume>:<fpage>73</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-013-3069-8</pub-id>
<?supplied-pmid 24196189?><pub-id pub-id-type="pmid">24196189</pub-id></mixed-citation></ref><ref id="pone.0173337.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name>, <name><surname>Church</surname><given-names>TS</given-names></name>, <name><surname>Craig</surname><given-names>CL</given-names></name>, <name><surname>Bouchard</surname><given-names>C</given-names></name>. <article-title>Sitting time and mortality from all causes, cardiovascular disease, and cancer</article-title>. <source>Med Sci Sports Exerc</source>. <year>2009</year>; <volume>41</volume>:<fpage>998</fpage>&#x02013;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0b013e3181930355</pub-id>
<?supplied-pmid 19346988?><pub-id pub-id-type="pmid">19346988</pub-id></mixed-citation></ref><ref id="pone.0173337.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Dunstan</surname><given-names>DW</given-names></name>, <name><surname>Barr</surname><given-names>EL</given-names></name>, <name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Salmon</surname><given-names>J</given-names></name>, <name><surname>Shaw</surname><given-names>JE</given-names></name>, <name><surname>Balkau</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab)</article-title>. <source>Circulation</source>. <year>2010</year>; <volume>121</volume>:<fpage>384</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.894824</pub-id>
<?supplied-pmid 20065160?><pub-id pub-id-type="pmid">20065160</pub-id></mixed-citation></ref><ref id="pone.0173337.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Thorp</surname><given-names>AA</given-names></name>, <name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Owen</surname><given-names>N</given-names></name>, <name><surname>Salmon</surname><given-names>J</given-names></name>, <name><surname>Ball</surname><given-names>K</given-names></name>, <name><surname>Shaw</surname><given-names>JE</given-names></name>, <etal>et al</etal>
<article-title>Deleterious associations of sitting time and television viewing time with cardiometabolic risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004&#x02013;2005</article-title>. <source>Diabetes Care</source>. <year>2010</year>; <volume>33</volume>: <fpage>327</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.2337/dc09-0493</pub-id>
<?supplied-pmid 19918003?><pub-id pub-id-type="pmid">19918003</pub-id></mixed-citation></ref><ref id="pone.0173337.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Matthews</surname><given-names>CE</given-names></name>, <name><surname>Dunstan</surname><given-names>DW</given-names></name>, <name><surname>Winkler</surname><given-names>EA</given-names></name>, <name><surname>Owen</surname><given-names>N</given-names></name>. <article-title>Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003&#x02013;06</article-title>. <source>Eur Heart J</source>. <year>2011</year>; <volume>32</volume>:<fpage>590</fpage>&#x02013;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehq451</pub-id>
<?supplied-pmid 21224291?><pub-id pub-id-type="pmid">21224291</pub-id></mixed-citation></ref><ref id="pone.0173337.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Colberg</surname><given-names>SR</given-names></name>, <name><surname>Sigal</surname><given-names>RJ</given-names></name>, <name><surname>Fernhall</surname><given-names>B</given-names></name>, <name><surname>Regensteiner</surname><given-names>JG</given-names></name>, <name><surname>Blissmer</surname><given-names>BJ</given-names></name>, <name><surname>Rubin</surname><given-names>RR</given-names></name>, <etal>et al</etal>
<article-title>Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement</article-title>. <source>Diabetes Care</source>. <year>2010</year>; <volume>33</volume>:<fpage>e147</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.2337/dc10-9990</pub-id>
<?supplied-pmid 21115758?><pub-id pub-id-type="pmid">21115758</pub-id></mixed-citation></ref><ref id="pone.0173337.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name>. <article-title>Physical activity, sedentary behavior, and health: paradigm paralysis or paradigm shift?</article-title>
<source>Diabetes</source>. <year>2010</year>; <volume>59</volume>:<fpage>2717</fpage>&#x02013;<lpage>2725</lpage>. <pub-id pub-id-type="doi">10.2337/db10-0822</pub-id>
<?supplied-pmid 20980470?><pub-id pub-id-type="pmid">20980470</pub-id></mixed-citation></ref><ref id="pone.0173337.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Owen</surname><given-names>N</given-names></name>, <name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Matthews</surname><given-names>CE</given-names></name>, <name><surname>Dunstan</surname><given-names>DW</given-names></name>. <article-title>Too much sitting: the population health science of sedentary behavior</article-title>. <source>Exerc Sport Sci Rev</source>. <year>2010</year>; <volume>38</volume>:<fpage>105</fpage>&#x02013;<lpage>113</lpage>. <?supplied-pmid 20577058?><pub-id pub-id-type="pmid">20577058</pub-id></mixed-citation></ref><ref id="pone.0173337.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Winkler</surname><given-names>EA</given-names></name>, <name><surname>Owen</surname><given-names>N</given-names></name>, <name><surname>Anuradha</surname><given-names>S</given-names></name>, <name><surname>Dunstan</surname><given-names>DW</given-names></name>. <article-title>Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers</article-title>. <source>Eur Heart J</source>. <year>2015</year>; <volume>36</volume>:<fpage>2643</fpage>&#x02013;<lpage>2649</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehv308</pub-id>
<?supplied-pmid 26228867?><pub-id pub-id-type="pmid">26228867</pub-id></mixed-citation></ref><ref id="pone.0173337.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Sigal</surname><given-names>RJ</given-names></name>, <name><surname>Kenny</surname><given-names>GP</given-names></name>, <name><surname>Wasserman</surname><given-names>DP</given-names></name>, <name><surname>Castaneda-Sceppa</surname><given-names>C</given-names></name>. <article-title>Physical activity/exercise and type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2004</year>; <volume>27</volume>:<fpage>2518</fpage>&#x02013;<lpage>2539</lpage>. <?supplied-pmid 15451933?><pub-id pub-id-type="pmid">15451933</pub-id></mixed-citation></ref><ref id="pone.0173337.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Sacchetti</surname><given-names>M</given-names></name>, <name><surname>Haxhi</surname><given-names>J</given-names></name>, <name><surname>Orlando</surname><given-names>G</given-names></name>, <name><surname>D'Errico</surname><given-names>V</given-names></name>, <name><surname>Fallucca</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Physical exercise as therapy for type 2 diabetes mellitus</article-title>. <source>Diabetes Metab Res Rev</source>. <year>2014</year>; <volume>30</volume> (<issue>Suppl 1</issue>):<fpage>13</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">24353273</pub-id></mixed-citation></ref><ref id="pone.0173337.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Korkiakangas</surname><given-names>EE</given-names></name>, <name><surname>Alahuhta</surname><given-names>MA</given-names></name>, <name><surname>Laitinen</surname><given-names>JH</given-names></name>. <article-title>Barriers to regular exercise among adults at high risk or diagnosed with type 2 diabetes: a systematic review</article-title>. <source>Health Promot Int</source>. <year>2009</year>; <volume>24</volume>:<fpage>416</fpage>&#x02013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1093/heapro/dap031</pub-id>
<?supplied-pmid 19793763?><pub-id pub-id-type="pmid">19793763</pub-id></mixed-citation></ref><ref id="pone.0173337.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>, <name><surname>Nicolucci</surname><given-names>A</given-names></name>, <name><surname>De Feo</surname><given-names>P</given-names></name>, <name><surname>Cavallo</surname><given-names>S</given-names></name>, <name><surname>Cardelli</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES)</article-title>. <source>Arch Intern Med</source>. <year>2010</year>; <volume>170</volume>:<fpage>1794</fpage>&#x02013;<lpage>1803</lpage>. <?supplied-pmid 21059972?><pub-id pub-id-type="pmid">21059972</pub-id></mixed-citation></ref><ref id="pone.0173337.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Di Loreto</surname><given-names>C</given-names></name>, <name><surname>Fanelli</surname><given-names>C</given-names></name>, <name><surname>Lucidi</surname><given-names>P</given-names></name>, <name><surname>Murdolo</surname><given-names>G</given-names></name>, <name><surname>De Cicco</surname><given-names>A</given-names></name>, <name><surname>Parlanti</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects</article-title>. <source>Diabetes Care</source>. <year>2003</year>; <volume>26</volume>:<fpage>404</fpage>&#x02013;<lpage>408</lpage>. <?supplied-pmid 12547870?><pub-id pub-id-type="pmid">12547870</pub-id></mixed-citation></ref><ref id="pone.0173337.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Nicolucci</surname><given-names>A</given-names></name>, <name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Cardelli</surname><given-names>P</given-names></name>, <name><surname>Cavallo</surname><given-names>S</given-names></name>, <name><surname>Fallucca</surname><given-names>S</given-names></name>, <name><surname>Bazuro</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)</article-title>. <source>Diabetologia</source>. <year>2012</year>; <volume>55</volume>:<fpage>579</fpage>&#x02013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-011-2425-9</pub-id>
<?supplied-pmid 22234648?><pub-id pub-id-type="pmid">22234648</pub-id></mixed-citation></ref><ref id="pone.0173337.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Yates</surname><given-names>T</given-names></name>, <name><surname>Davies</surname><given-names>M</given-names></name>, <name><surname>Gorely</surname><given-names>T</given-names></name>, <name><surname>Bull</surname><given-names>F</given-names></name>, <name><surname>Khunti</surname><given-names>K</given-names></name>. <article-title>Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial</article-title>. <source>Diabetes Care</source>. <year>2009</year>; <volume>32</volume>:<fpage>1404</fpage>&#x02013;<lpage>1410</lpage>. <pub-id pub-id-type="doi">10.2337/dc09-0130</pub-id>
<?supplied-pmid 19602539?><pub-id pub-id-type="pmid">19602539</pub-id></mixed-citation></ref><ref id="pone.0173337.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Kokkinos</surname><given-names>P</given-names></name>, <name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Nylen</surname><given-names>E</given-names></name>, <name><surname>Panagiotakos</surname><given-names>DB</given-names></name>, <name><surname>Manolis</surname><given-names>A</given-names></name>, <name><surname>Pittaras</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2009</year>; <volume>32</volume>:<fpage>623</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.2337/dc08-1876</pub-id>
<?supplied-pmid 19196898?><pub-id pub-id-type="pmid">19196898</pub-id></mixed-citation></ref><ref id="pone.0173337.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Ekelund</surname><given-names>U</given-names></name>, <name><surname>Ward</surname><given-names>HA</given-names></name>, <name><surname>Norat</surname><given-names>T</given-names></name>, <name><surname>Luan</surname><given-names>J</given-names></name>, <name><surname>May</surname><given-names>AM</given-names></name>, <name><surname>Weiderpass</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)</article-title>. <source>Am J Clin Nutr</source>. <year>2015</year>; <volume>101</volume>: <fpage>613</fpage>&#x02013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.114.100065</pub-id>
<?supplied-pmid 25733647?><pub-id pub-id-type="pmid">25733647</pub-id></mixed-citation></ref><ref id="pone.0173337.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Shephard</surname><given-names>RJ</given-names></name>. <article-title>Limits to the measurement of habitual physical activity by questionnaires</article-title>. <source>Br J Sports Med</source>. <year>2003</year>; <volume>37</volume>:<fpage>197</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1136/bjsm.37.3.197</pub-id>
<?supplied-pmid 12782543?><pub-id pub-id-type="pmid">12782543</pub-id></mixed-citation></ref><ref id="pone.0173337.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Healy</surname><given-names>GN</given-names></name>, <name><surname>Dunstan</surname><given-names>DW</given-names></name>, <name><surname>Salmon</surname><given-names>J</given-names></name>, <name><surname>Cerin</surname><given-names>E</given-names></name>, <name><surname>Shaw</surname><given-names>JE</given-names></name>, <name><surname>Zimmet</surname><given-names>PZ</given-names></name>, <etal>et al</etal>
<article-title>Objectively measured light-intensity physical activity is independently associated with 2-h plasma glucose</article-title>. <source>Diabetes Care</source>. <year>2007</year>; <volume>30</volume>:<fpage>1384</fpage>&#x02013;<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.2337/dc07-0114</pub-id>
<?supplied-pmid 17473059?><pub-id pub-id-type="pmid">17473059</pub-id></mixed-citation></ref><ref id="pone.0173337.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Sacchetti</surname><given-names>M</given-names></name>, <name><surname>Haxhi</surname><given-names>J</given-names></name>, <name><surname>Orlando</surname><given-names>G</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>, <name><surname>Cardelli</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>The Italian Diabetes and Exercise Study 2 (IDES-2): a long-term behavioral intervention for adoption and maintenance of a physically active lifestyle</article-title>. <source>Trials</source>. <year>2015</year>; <volume>16</volume>:<fpage>569</fpage>
<pub-id pub-id-type="doi">10.1186/s13063-015-1088-0</pub-id>
<?supplied-pmid 26651484?><pub-id pub-id-type="pmid">26651484</pub-id></mixed-citation></ref><ref id="pone.0173337.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Inoue</surname><given-names>M</given-names></name>, <name><surname>Iso</surname><given-names>H</given-names></name>, <name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Kurahashi</surname><given-names>N</given-names></name>, <name><surname>Iwasaki</surname><given-names>M</given-names></name>, <name><surname>Sasazuki</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Daily total physical activity level and premature death in men and women: results from a large-scale population-based cohort study in Japan (JPHC study)</article-title>. <source>Ann Epidemiol</source>. <year>2008</year>; <volume>18</volume>:<fpage>522</fpage>&#x02013;<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2008.03.008</pub-id>
<?supplied-pmid 18504139?><pub-id pub-id-type="pmid">18504139</pub-id></mixed-citation></ref><ref id="pone.0173337.ref030"><label>30</label><mixed-citation publication-type="journal"><collab>Sedentary Behaviour Research Network</collab>. <article-title>Letter to the Editor: Standardized use of the terms &#x0201c;sedentary&#x0201d; and &#x0201c;sedentary behaviours&#x0201d;</article-title>. <source>Appl Physiol Nutr Metab</source>. <year>2012</year>; <volume>37</volume>:<fpage>540</fpage>&#x02013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1139/h2012-024</pub-id>
<?supplied-pmid 22540258?><pub-id pub-id-type="pmid">22540258</pub-id></mixed-citation></ref><ref id="pone.0173337.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>, <name><surname>Massarini</surname><given-names>M</given-names></name>, <name><surname>Corigliano</surname><given-names>G</given-names></name>, <name><surname>Nicolucci</surname><given-names>A</given-names></name>, <name><surname>Missori</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>The Italian Diabetes and Exercise Study (IDES): Design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetic and the metabolic Syndrome</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2008</year>; <volume>18</volume>:<fpage>585</fpage>&#x02013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2007.07.006</pub-id>
<?supplied-pmid 18061415?><pub-id pub-id-type="pmid">18061415</pub-id></mixed-citation></ref><ref id="pone.0173337.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Herrmann</surname><given-names>SD</given-names></name>, <name><surname>Hart</surname><given-names>TL</given-names></name>, <name><surname>Lee</surname><given-names>CD</given-names></name>, <name><surname>Ainsworth</surname><given-names>BE</given-names></name>. <article-title>Evaluation of the MyWellness Key accelerometer</article-title>. <source>Br J Sports Med</source>. <year>2011</year>; <volume>45</volume>:<fpage>109</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1136/bjsm.2009.062182</pub-id>
<?supplied-pmid 19736173?><pub-id pub-id-type="pmid">19736173</pub-id></mixed-citation></ref><ref id="pone.0173337.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Bergamin</surname><given-names>M</given-names></name>, <name><surname>Ermolao</surname><given-names>A</given-names></name>, <name><surname>Sieverdes</surname><given-names>JC</given-names></name>, <name><surname>Zaccaria</surname><given-names>M</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>. <article-title>Validation of the MyWellness Key in walking and running speeds</article-title>. <source>J Sports Sci Med</source>. <year>2012</year>; <volume>11</volume>:<fpage>57</fpage>&#x02013;<lpage>63</lpage>. <?supplied-pmid 24149122?><pub-id pub-id-type="pmid">24149122</pub-id></mixed-citation></ref><ref id="pone.0173337.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Sieverdes</surname><given-names>JC</given-names></name>, <name><surname>Wickel</surname><given-names>EE</given-names></name>, <name><surname>Hand</surname><given-names>GA</given-names></name>, <name><surname>Bergamin</surname><given-names>M</given-names></name>, <name><surname>Moran</surname><given-names>RR</given-names></name>, <name><surname>Blair</surname><given-names>SN</given-names></name>. <article-title>Reliability and validity of the Mywellness Key physical activity monitor</article-title>. <source>Clin Epidemiol</source>. <year>2013</year>; <volume>5</volume>:<fpage>13</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S38370</pub-id>
<?supplied-pmid 23378783?><pub-id pub-id-type="pmid">23378783</pub-id></mixed-citation></ref><ref id="pone.0173337.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>McGinley</surname><given-names>SK</given-names></name>, <name><surname>Armstrong</surname><given-names>MJ</given-names></name>, <name><surname>Khandwala</surname><given-names>F</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>, <name><surname>Sigal</surname><given-names>RJ</given-names></name>. <article-title>Assessment of the MyWellness Key accelerometer in people with type 2 diabetes</article-title>. <source>Appl Physiol Nutr Metab</source>. <year>2015</year>; <volume>40</volume>:<fpage>1193</fpage>&#x02013;<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1139/apnm-2015-0169</pub-id>
<?supplied-pmid 26489052?><pub-id pub-id-type="pmid">26489052</pub-id></mixed-citation></ref><ref id="pone.0173337.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Sacchetti</surname><given-names>M</given-names></name>, <name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Bazzucchi</surname><given-names>I</given-names></name>, <name><surname>Carlucci</surname><given-names>F</given-names></name>, <name><surname>Scotto di Palumbo</surname><given-names>A</given-names></name>, <name><surname>Haxhi</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Neuromuscular dysfunction in diabetes: role of nerve impairment and training status</article-title>. <source>Med Sci Sports Exerc</source>. <year>2013</year>; <volume>45</volume>:<fpage>52</fpage>&#x02013;<lpage>59</lpage>. <?supplied-pmid 22843109?><pub-id pub-id-type="pmid">22843109</pub-id></mixed-citation></ref><ref id="pone.0173337.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Penno</surname><given-names>G</given-names></name>, <name><surname>Solini</surname><given-names>A</given-names></name>, <name><surname>Bonora</surname><given-names>E</given-names></name>, <name><surname>Fondelli</surname><given-names>C</given-names></name>, <name><surname>Orsi</surname><given-names>E</given-names></name>, <name><surname>Zerbini</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study</article-title>. <source>J Intern Med</source>. <year>2013</year>; <volume>274</volume>:<fpage>176</fpage>&#x02013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12073</pub-id>
<?supplied-pmid 23565931?><pub-id pub-id-type="pmid">23565931</pub-id></mixed-citation></ref><ref id="pone.0173337.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Febbraio</surname><given-names>MA</given-names></name>. <article-title>Exercise and inflammation</article-title>. <source>J Appl Physiol (1985)</source>. <year>2007</year>; <volume>103</volume>:<fpage>376</fpage>&#x02013;<lpage>377</lpage>.<pub-id pub-id-type="pmid">17446409</pub-id></mixed-citation></ref><ref id="pone.0173337.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Balducci</surname><given-names>S</given-names></name>, <name><surname>Zanuso</surname><given-names>S</given-names></name>, <name><surname>Nicolucci</surname><given-names>A</given-names></name>, <name><surname>Fernando</surname><given-names>F</given-names></name>, <name><surname>Cavallo</surname><given-names>S</given-names></name>, <name><surname>Cardelli</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2010</year>; <volume>20</volume>:<fpage>608</fpage>&#x02013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2009.04.015</pub-id>
<?supplied-pmid 19695853?><pub-id pub-id-type="pmid">19695853</pub-id></mixed-citation></ref></ref-list></back></article>